Showing 5751-5760 of 21474 results for "".
- FDA Clears Cutera truFlex® for Muscle Rehab, Recovery, and Post-Surgical Usehttps://reachmd.com/news/fda-clears-cutera-truflex-for-muscle-rehab-recovery-and-post-surgical-use/2485023/Cutera, Inc. has announced that its truFlex® muscle stimulation system has received expanded US Food and Drug Administration (FDA) clearances for use in rehabilitation, recovery, and muscle wellness applications. Originally cleared for aesthetic body contouring, the system can now be used to stre
- New Study Supports Efficacy of Noninvasive Ultrasound for Cellulitehttps://reachmd.com/news/new-study-supports-efficacy-of-noninvasive-ultrasound-for-cellulite/2485014/A novel ultrasound-based device featuring synchronous parallel beam technology with a high-density handpiece demonstrated significant improvement in the appearance of cellulite, according to findings from a new multicenter study published in Dermatologic Surgery. The open-label, n
- Vixarelimab Shows Dose-Dependent Efficacy in Prurigo Nodularis Phase 2b Trialhttps://reachmd.com/news/vixarelimab-shows-dose-dependent-efficacy-in-prurigo-nodularis-phase-2b-trial/2484982/Vixarelimab demonstrated dose-dependent improvements in itch severity and skin lesion clearance in patients with moderate to severe prurigo nodularis (PN), according to new results from a phase 2b randomized clinical trial. Res
- Emerging Biomarkers for Predicting and Mitigating Cardiotoxicity in Breast Cancer Treatmenthttps://reachmd.com/news/emerging-biomarkers-for-predicting-and-mitigating-cardiotoxicity-in-breast-cancer-treatment/2484992/Circulating microRNA profiling identifies candidates that predict cardiotoxic risk in HER2-positive breast cancer patients receiving anthracyclines and trastuzumab, offering a data-driven route to earlier detection. This update gives clinicians concise, actionable evidence
- Harnessing Nutrition for Healthy Aging: Beetroot Juice and Beyondhttps://reachmd.com/news/harnessing-nutrition-for-healthy-aging-beetroot-juice-and-beyond/2484987/Beetroot-derived nitrates reliably improve endurance and muscular power in recreational and older adults, offering a practical, food-based ergogenic strategy that leverages nitric oxide physiology. Systematic-review–level evidence across randomized trials and pooled analyse
- Efficacy of Myofascial Release vs. Therapeutic Ultrasound in Treating Trapezius Trigger Points in Athleteshttps://reachmd.com/news/myofascial-release-trapezius-trigger-athletes/2484979/A randomized clinical trial found that targeted myofascial release produced greater pain reduction and functional improvement than stretching plus therapeutic ultrasound in a
- Zasocitinib: A Promising Oral Solution for Plaque Psoriasishttps://reachmd.com/news/zasocitinib-a-promising-oral-solution-for-plaque-psoriasis/2484984/Takeda’s oral TYK2 inhibitor zasocitinib demonstrated robust skin clearance in pivotal Phase 3 trials, according to the
- Zasocitinib Phase 3 Data Suggests Potential for Once-Daily Psoriasis Pillhttps://reachmd.com/news/zasocitinib-phase-3-data-sugges-potential-for-once-daily-psoriasis-pill/2484981/Oral TYK2 inhibitor zasocitinib (TAK-279) met all primary and 44 ranked secondary endpoints in two pivotal Phase 3 trials for moderate-to-severe plaque psoriasis, according to a December 18 press release from Takeda. Results f
- FDA Approval: Depemokimab in Severe Eosinophilic Asthmahttps://reachmd.com/news/asthma-treatment-evolution-immediate-approvals-and-future-directions/2484980/The FDA has approved depemokimab as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents. The authorization immediatel
- Uncovering Bias in AI Pathology Modelshttps://reachmd.com/news/bias-ai-pathology-models/2484966/Harvard Medical School researchers have identified demographic bias in pathology AI models that measurably reduced diagnostic performance across